NO20060912L - Preoperativ behandling for postoperativ smerte - Google Patents

Preoperativ behandling for postoperativ smerte

Info

Publication number
NO20060912L
NO20060912L NO20060912A NO20060912A NO20060912L NO 20060912 L NO20060912 L NO 20060912L NO 20060912 A NO20060912 A NO 20060912A NO 20060912 A NO20060912 A NO 20060912A NO 20060912 L NO20060912 L NO 20060912L
Authority
NO
Norway
Prior art keywords
postoperative pain
preoperative treatment
surgery
dosage form
patient
Prior art date
Application number
NO20060912A
Other languages
English (en)
Other versions
NO326636B1 (no
Inventor
Bruce E Reidenberg
Daniel A Spyker
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of NO20060912L publication Critical patent/NO20060912L/no
Publication of NO326636B1 publication Critical patent/NO326636B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Processing Of Meat And Fish (AREA)
  • Prostheses (AREA)
NO20060912A 2003-07-25 2006-02-24 Anvendelse av buprenorfin NO326636B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25
PCT/US2004/024009 WO2005011578A2 (en) 2003-07-25 2004-07-26 Preoperative treatment of post operative pain

Publications (2)

Publication Number Publication Date
NO20060912L true NO20060912L (no) 2006-04-21
NO326636B1 NO326636B1 (no) 2009-01-26

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060912A NO326636B1 (no) 2003-07-25 2006-02-24 Anvendelse av buprenorfin

Country Status (28)

Country Link
US (3) US20080026042A1 (no)
EP (1) EP1638492B1 (no)
JP (1) JP5632573B2 (no)
KR (4) KR20060054346A (no)
CN (1) CN1829489B (no)
AT (1) ATE382354T1 (no)
AU (1) AU2004261181B2 (no)
BR (1) BRPI0412924A (no)
CA (1) CA2529983C (no)
CY (1) CY1107352T1 (no)
DE (1) DE602004011055T2 (no)
DK (1) DK1638492T3 (no)
EA (1) EA009213B1 (no)
ES (1) ES2299871T3 (no)
GE (1) GEP201606538B (no)
HK (1) HK1087907A1 (no)
HR (1) HRP20080146T3 (no)
IL (1) IL173345A (no)
IS (1) IS8186A (no)
MA (1) MA28005A1 (no)
MX (1) MXPA06000990A (no)
NO (1) NO326636B1 (no)
NZ (1) NZ594154A (no)
PL (1) PL1638492T3 (no)
PT (1) PT1638492E (no)
UA (1) UA81689C2 (no)
WO (1) WO2005011578A2 (no)
ZA (1) ZA200510071B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
DK2611445T3 (en) * 2010-09-03 2018-10-22 Zoetis Belgium S A HIGH DOSAGE-BUPRENORPHINE COMPOSITIONS AND USE AS ANALGETIC
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела
WO2024055006A2 (en) * 2022-09-09 2024-03-14 The Regents Of The University Of California Compositions for preventing transition from acute to chronic pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
AU637496B2 (en) * 1990-04-24 1993-05-27 Teijin Limited Plaster
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
WO2001093868A1 (fr) * 2000-06-02 2001-12-13 Teijin Limited Bande adhesive contenant de la buprenorphine
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
EP2266719B1 (en) * 2001-04-23 2016-06-08 Euro-Celtique S.A. Disposal system for transdermal dosage form
DK2062573T3 (da) * 2001-05-01 2012-01-30 Euro Celtique Sa Misbrugsresistent opioid indeholdende transdermale systemer
PT1390866E (pt) * 2001-05-22 2010-04-26 Euro Celtique Sa Recipiente e processo para distribuição de formas de dosagem transdérmicas
AU2003297073A1 (en) * 2002-12-13 2004-07-09 Euro-Celtique S.A. Transdermal buprenorphine dosage regimen for analgesia

Also Published As

Publication number Publication date
MXPA06000990A (es) 2006-04-11
HK1087907A1 (en) 2006-10-27
ES2299871T3 (es) 2008-06-01
CA2529983A1 (en) 2005-02-10
AU2004261181A1 (en) 2005-02-10
EA200600284A1 (ru) 2006-06-30
IL173345A (en) 2010-06-16
ZA200510071B (en) 2006-11-29
WO2005011578A2 (en) 2005-02-10
KR20080011248A (ko) 2008-01-31
PL1638492T3 (pl) 2008-06-30
JP2007500133A (ja) 2007-01-11
ATE382354T1 (de) 2008-01-15
BRPI0412924A (pt) 2006-09-26
DE602004011055T2 (de) 2008-12-18
CN1829489B (zh) 2010-12-15
US20140221413A1 (en) 2014-08-07
AU2004261181B2 (en) 2009-08-06
CY1107352T1 (el) 2012-12-19
KR20120128715A (ko) 2012-11-27
US20110002975A1 (en) 2011-01-06
DK1638492T3 (da) 2008-05-13
EP1638492B1 (en) 2008-01-02
DE602004011055D1 (de) 2008-02-14
WO2005011578A3 (en) 2005-09-09
KR20090031961A (ko) 2009-03-30
UA81689C2 (ru) 2008-01-25
PT1638492E (pt) 2008-03-17
NZ594154A (en) 2012-12-21
IL173345A0 (en) 2006-06-11
JP5632573B2 (ja) 2014-11-26
IS8186A (is) 2005-12-19
CN1829489A (zh) 2006-09-06
KR20060054346A (ko) 2006-05-22
CA2529983C (en) 2010-07-20
MA28005A1 (fr) 2006-07-03
US20080026042A1 (en) 2008-01-31
GEP201606538B (en) 2016-09-12
EP1638492A2 (en) 2006-03-29
EP1638492A4 (en) 2006-07-19
EA009213B1 (ru) 2007-12-28
NO326636B1 (no) 2009-01-26
HRP20080146T3 (en) 2008-04-30

Similar Documents

Publication Publication Date Title
NO20060912L (no) Preoperativ behandling for postoperativ smerte
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
BRPI0406667A (pt) Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg
DE60326354D1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
EA200600820A1 (ru) Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина
IS8187A (is) Meðferð á fráhvarfseinkennum
ATE394097T1 (de) Verfahren zur verabreichung von buprenorphin zur behandlung von depression
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
GB0405381D0 (en) A method and means for treating heart failure
ATE330600T1 (de) Kombinationspräparat zur krebstherapie
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
UA135218U (uk) Спосіб лікування післяопераційного болю після лапароскопічних втручань
DE60108775D1 (de) Methode zur behandlung von schlaganfall
RU2006124481A (ru) Способ лечения трофических язв при синдроме "диабетической стопы"

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees